EQTEC announces capital reorganisation to reduce share nominal value

EQTEC plc (AIM:EQT) is proposing a capital reorganisation to address its inability to raise funds via equity issuance, as its shares currently trade below their nominal value of €0.01. The plan, requiring shareholder approval by September 25, 2025, involves subdividing each existing ordinary share into one new ordinary share of €0.0001 and one unlisted deferred share of €0.0099. This strategic move aims to lower the nominal value, providing the syngas technology licensor with critical financial flexibility for future capital raises without altering current shareholders' proportionate interests or aggregate holdings.

Analysis

EQTEC plc is undertaking a capital reorganisation to resolve a critical financing constraint, as its shares trading below their nominal value of €0.01 on the AIM market legally prohibits new equity issuance under Irish law. The proposed solution is a technical share subdivision, converting each existing share into a new ordinary share with a nominal value of €0.0001 and a non-trading deferred share. This maneuver, contingent on shareholder approval at the September 25, 2025 AGM, is designed solely to lower the nominal value floor, thereby restoring the company's ability to access equity markets for funding. While the reorganisation is structurally neutral for existing shareholders in terms of proportionate ownership and the total number of issued shares (640,657,138), its necessity highlights the company's depressed valuation and current inability to fund its operations or growth via the public market. Management's concurrent request for authority to issue new shares confirms that a capital raise is the intended next step following a successful reorganisation.

Key Decisions for Investors

• Investors should anticipate a potentially dilutive equity issuance following the reorganisation, as its primary purpose is to enable the company to raise fresh capital.
• The shareholder vote on September 25, 2025, represents a significant near-term catalyst; failure to secure approval would perpetuate the company's financing limitations and likely increase pressure on the share price.
• Focus should shift to scrutinizing management's strategy for deploying any new funds raised, as long-term value will be driven by the operational use of capital, not the technical success of this balance sheet restructuring.